Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Philadelphia, Pennsylvania 19124


Purpose:

The purpose of this study is to investigate the effect of the ReBuilder in the treatment of individuals with breast cancer and chemotherapy induced peripheral neuropathy.


Criteria:

Inclusion Criteria: - Patients with breast cancer referred to Physical Therapy for CIPN - Physical Therapy Examination indicates use of Rebuilder for CIPN - At least 18 years of age - Signed informed consent for study population - Willingness to complete study according to protocol Exclusion Criteria: - Patients who do not have CIPN - Patients <18 years of age - Inability to or unwilling to sign informed consent - Unable to read and understand the English language - Preexisting sensory peripheral neuropathy from other comorbid conditions such as diabetes or alcoholism - More than three (3) prior ReBuilder treatments; OR ReBuilder within the last 30 days, for sensory peripheral neuropathy


NCT ID:

NCT02606110


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Philadelphia, Pennsylvania 19124
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.